Prevention and Treatment of Influenza Diseases with Traditional Chinese Medicine

Status

Recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2100045928

Enrollment

Unknown

Registered

2021-04-28

Start date

2021-05-31

Completion date

Unknown

Last updated

2021-12-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Influenza

Interventions

experimental group:Traditional Chinese Medicine or Traditional Chinese Medicine combined with Oseltamivir

Control group:Oseltamivir

Eligibility

Sex/Gender

All

Age

1 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Diagnosed with influenza, age and gender are not limited; 2. Give Traditional Chinese medicine or Traditional Chinese medicine combined with oseltamivir; 3. Visited Nanfang Hospital of Southern Medical University, Zhujiang Hospital of Southern Medical University, and Nanhai Hospital of Southern Medical University; 4. Sign the informed consent form.

Exclusion criteria

Exclusion criteria: 1. The first diagnosis was other serious diseases combined with influenza; 2. The route of administration of Traditional Chinese medicine is not oral; 3. Patients judged by the investigator to be unsuitable for participation in this study 4. No case history data or test results missing.

Design outcomes

Primary

Measure	Time frame
Cough, sore throat;Fever duration;Time to fever;	—

Secondary

Measure	Time frame
Hospital stay;Duration of symptoms;	—

Countries

China

Contacts

Public ContactLiu Shuwen

Nanfang Hospital of Southern Medical University

liusw@smu.edu.cn+86 13925020236

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026